Journal article
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation
Abstract
BACKGROUND: Oral anticoagulants may improve the survival of people with cancer through an antithrombotic effect, yet increase the risk of bleeding.
OBJECTIVES: To evaluate the efficacy and safety of oral anticoagulants in ambulatory people with cancer undergoing chemotherapy, targeted therapy, immunotherapy, or radiotherapy (either alone or in combination), with no standard therapeutic or prophylactic indication for anticoagulation.
Authors
Kahale LA; Matar CF; Tsolakian I; Hakoum MB; Barba M; Yosuico VE; Terrenato I; Sperati F; Schünemann H; Akl EA
Journal
Cochrane Database of Systematic Reviews, Vol. 2023, No. 10,
Publisher
Wiley
DOI
10.1002/14651858.cd006466.pub7
ISSN
1361-6137